Vilya
PrivateLast Round
Series A
Jun 4, 2024
Total Funding Raised
$121M
Company Overview
Vilya is a biotechnology company that develops a unique platform for creating innovative medicines that precisely target disease biology through the design of novel molecular structures with essential drug-like properties.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vilya Comps
Public and private peers based on sector, stage, and business model.
Vilya Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 4, 2024 | ||||
| Series A | Aug 30, 2022 |
Key People
Founding team and executive leadership
Vilya Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Series A |
| Lifeforce Capital | Series A |
| ARCH Venture Partners | Series A |
| NVentures | Series A |
| Madrona Venture Group | Series A |
| Menlo Ventures | Series A |
Vilya Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vilya's valuation, stock price, and market status.
